Hemofiltration
Hemofiltration is a method based on the elimination of waste products from the individual's circulatory system. In contrast to hemodialysis, filtration uses convective transport of solutes through a hemofiltration semipermeable membrane. Own technical equipment is a dialysis monitor. It is a device that contains a blood pump that circulates extracorporeal blood from the patient's vascular access to the filter and back.
Principle[edit | edit source]
Blood is fed into extracorporeal circulation controlled by a dialysis monitor. Here, ultrafiltration (UF) of blood takes place through a semipermeable membrane, which shows a high degree of permeability even for molecules weighing up to 30,000 Da. This makes it possible to eliminate substances that cannot be removed by hemodialysis with a relatively high rate of success. During ultrafiltration, dissolved substances pass through the membrane together with the solvent (water). The speed of this transfer is influenced by many factors:
- transmembrane pressure – the difference in pressure gradients on both sides of the membrane.
– at zero pressure gradient, UF is zero and increases linearly with increasing effective pressure gradient.
- hemofilter ultrafiltration coefficient – determines the amount of ultrafiltrate at a pressure gradient of 1 torr in 1 hour.
The volume of the filtered liquid from the circulation is then replenished with a substitution solution. This is automatically continuously prepared in the dialysis monitor and consists of treated water and mineral substances in an amount that corresponds to the amount of hemofiltration.
Usage[edit | edit source]
Hemofiltration expands the possibilities of using extracorporeal elimination in addition to hemodialysis and hemodiafiltration. This form of organ support is suitable for long-term use (CVVH – continuous veno-venous hemofiltration , respectively CAVH – continuous arterio-venous hemofiltration ) as a kidney replacement in critical patients, for example with a coagulation disorder. It can also be indicated for acute renal failure in a critical state (renal/non-renal), uremia (oliguria to anuria), general sepsis, ARDS (Acute respiratory distress syndrome), MODS (Multiple organ dysfunction syndrome), hepatorenal syndrome, cardiac failure or metabolic disruption.
Links[edit | edit source]
References[edit | edit source]
- http://www.cskb.cz/res/file/biolaby/2010/1-Eiselt.pdf
- https://www.slideshare.net/HammerheadNC/1-prismaflex-crrt-intro-seg-1-2007-7394701
- https://web.archive.org/web/20160331222721/http://zdravi.e15.cz/clanek/sestra/kontinualni-mimotelni-nahrady-funkce-ledvin-v-intenzivni-peci-449176
- http://www.nefrologia.sk/clanky/poucenie-pre-pacientov-hemodialyza/302
- Ševela Kamil, Ševčík Pavel a kolektiv, Akutní intoxikace a léková poškození v intenzivní medicíně: 2., doplněné a aktualizované vydání, Grada Publishing a.s., 2011